跳至主要内容
临床试验/CTRI/2020/07/026568
CTRI/2020/07/026568招募中未知

Reducing the risk of developing symptomatic Corona virus disease and reducing requirement of hospitalization by administering Ayurveda Rasayana therapy as a prophylactic therapy to individuals residing Coronavirus Hotspots and having comorbidities which increases the risk of developing severe stage Coronavirus disease or ARDS

Ayurved Rasayani0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Individuals residing in Corona virus Hotspots as declared by Authorities
  • 2 Individuals having any of the following comorbidities
  • 3 Chronic Diabetic with more than 5 yearsof knownon set Chronic hypertensive with more than 5years of knownon set Patients with active malignancies or taking or taken anticancer therapy within last 6months Patients with chronic lowerrespiratory disease Patients with chronic liver or renalfailure Patients having immunosuppressivetherapies Or elderly person above 65 years of age with or without any comorbidities

排除标准

  • Pregnant women or women who are breast feeding
  • Consideration by the investigator for any reason that the subject is an unsuitable candidate to receive study treatment

研究者

相似试验